trial

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

NCTId NCT05741502
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Terminated
Enrollment 5 (actual)
Sponsored by Ohio State University
Primary completion 2026-01-23
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Terminated
Enrollment
5 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2023-08-16
Primary completion
2026-01-23
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Clozapine

Sponsors

Ohio State UniversityLead Sponsor

Sites

1 total
Columbus, United States

Facts & assertions

4 sourced
Enrollment
5
Phase
PHASE4
Primary Completion Date
2026-01-23
Status
TERMINATED
relationships
The graph out of here
drug
Clozapine
drug
lead_sponsor
Ohio State University
company
indication
Schizophrenia, Treatment-Resistant
indication
Treatment-resistant Schizophrenia
indication